EMA updates guideline on developing drugs for bipolar disorder
Regulatory NewsJoanne S. Eglovitch
Clinical TrialsEuropeEuropean Medicines Agency (EMA)GuidancePharmaceuticalsProduct developmentProject managementRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchClinical TrialsEuropeEuropean Medicines Agency (EMA)GuidancePharmaceuticalsProduct developmentProject managementRegulatory Intelligence/Policy